PureTech Health plc Logo

PureTech Health plc

A clinical-stage biotherapeutics company developing new medicines for devastating diseases.

PRTC | IL

Overview

Corporate Details

ISIN(s):
GB00BPVG5C82 (+2 more)
LEI:
213800LVPDNO2Z9T9I39
Country:
United States of America
Address:
6 TIDE STREET, 2210 BOSTON

Description

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 18:55
Results of AGM on June 16, 2025 – Update Statement
English 11.9 KB
2025-12-10 18:40
Holding(s) in Company
English 20.6 KB
2025-12-08 08:35
PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
English 23.7 KB
2025-12-05 19:10
PRTC's Gallop: Positive Initial Topline AML Data
English 26.5 KB
2025-11-18 18:40
Holding(s) in Company
English 23.7 KB
2025-11-07 19:30
Holding(s) in Company
English 23.7 KB
2025-11-03 15:10
PRTC: New LYT-200 AML Data + Update at ASH
English 24.0 KB
2025-10-22 08:00
PRTC: New IPF Data Show Benefit in Older Patients
English 23.8 KB
2025-10-17 18:30
Holding(s) in Company
English 25.4 KB
2025-10-14 08:00
Holding(s) in Company
English 25.3 KB
2025-10-10 18:59
Holding(s) in Company
English 25.4 KB
2025-10-09 19:10
Holding(s) in Company
English 25.4 KB
2025-10-01 08:00
Holding(s) in Company
English 52.0 KB
2025-09-29 08:00
PRTC: New IPF Data Show Switch Patients Stabilized
English 28.1 KB
2025-09-23 18:30
Holding(s) in Company
English 25.0 KB

Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PureTech Health plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PureTech Health plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.